Alterations in the level and function of the stimulatory guanyl nucleotide binding protein (GJ) from the cardiac sarcolemma were examined in a canine model of heart failure. The present study is based on our previous investigations that demonstrated both a loss of /3-adrenergic agonist high-affinity binding sites and a decreased adenylate cyclase activity in sarcolemma from failing hearts. Using cholera toxin and [32PJNAD, 
Introduction
The failing left ventricle (LV)' depends on adrenergic stimulation for maintenance of the compensated state. Braunwald and co-workers demonstrated in animals that the failing left ventricle has decreased responsiveness to sympathetic nerve stimulation (1) . They also demonstrated elevations in the levels of circulating catecholamines as well as depletion of tissue stores of norepinephrine (2) . More recent studies have assessed the status of adrenergic receptors in failing myocardium, both in experimental animals (3, 4) and in man (5) . The present study identifies a defect distal to the receptor in the transduction of adrenergic signals to the heart in left ventricular failure.
The j3-adrenergic receptor/adenylate cyclase system is a plasma membrane-bound protein assembly consisting of three major components: the /3-adrenergic receptor, which binds hormone; the adenylate cyclase catalytic unit, which synthesizes cAMP from ATP; and the stimulatory guanyl nucleotide binding protein (G,2) , which couples the receptor to These data were presented in part at the national meeting ofthe American Heart Association on 17 November 1986.
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1. Abbreviations used in this paper: Gpp(NH)p, 5'-guanylylimidodiphosphate; Gs, stimulatory guanyl nucleotide-binding protein; GS,, alpha subunit of G,; LV, left ventricle.
adenylate cyclase (6, 7). Data from our laboratories suggest that alterations in adrenergic control of failing myocardium occur at many levels. In a canine model of LV failure induced by chronic pressure overload, the number of myocardial ,Badrenergic receptors was found to increase (4, 8) . Despite this increase, the number of high-affinity ,B-adrenergic agonist binding sites, which results from the coupling of agonist-occupied /3-adrenergic receptor to G, (9) , was reduced fourfold (4) . (4) . This suggested the possibility of an abnormality in the coupling between G, and adenylate cyclase. This finding was specific to the hypertrophied, failing left ventricle; it was not observed in membranes prepared from the unaffected right ventricle. The present study was undertaken to further define potential abnormalities of G, in heart failure that would explain these observations. We report here that G, appears to be deficient or defective in sarcolemma from failing left ventricle as assessed by both cholera toxin labeling and reconstitution studies.
Methods
The animal model predominantly used in this study is described by Kleinman et al. (10) , and has been utilized previously in our laboratories (4, 8) . Mongrel puppies of either sex at 7-10 wk of age underwent thoracotomy, and a teflon cuff was placed around the ascending aorta. After a period of 9 mo to 2 yr, during which the animals developed left ventricular hypertrophy, left ventricular failure ensued. Normal controls were either sham-operated or not operated. One adult animal underwent unilateral wrapping of a kidney and contralateral nephrectomy as described ( 1 1 (12) . Briefly, the hearts were excised and placed into Krebs- Ringers solution. Approximately 1 mm of epicardium and endocardium was removed with scissors and discarded. Left ventricular myo-washing the homogenate in the buffers described except that 0.75 M NaCl was used in the first buffer instead of 0.75 M KCI. The sarcolemmal component was obtained by floating crude membranes through a sucrose density gradient. Membranes were quickly frozen in a dry ice-acetone bath and stored at -70°C until further use.
Cholera toxin labeling. Quantitation ofcholera toxin substrate was performed as previously described by our laboratory (13) . Sarcolemmal membranes (10 Mg membrane protein) were mixed with membranes prepared from a Gj-deficient variant of the S49 mouse lymphoma cell line cyc-(40 ug membrane protein) in 250 Ml of buffer (100 mM Tris-HCl, 5 mM MgCl2, 1 mM EDTA, pH 7.4). Cyc-membranes were added to provide a source of ADP-ribosylation factor, which is necessary for the cholera toxin reaction but is absent from sarcolemmal membranes (13) . 100 Ml of an assay buffer (250 mM potassium phosphate, pH 7.0, 40 mM phosphocreatine, 20 mM thymidine, 1 13 U/ml creatine phosphokinase, 10 mM ATP, 0.5 mM GTP, and 2.5 mM NADP) was added to this. Activated cholera toxin (1 mg/ml) was prepared in a buffer of 50 mM Hepes, 135 mM NaCl, 5 mM dithiothreitol, pH 7.4, and was incubated at 37°C for 30 min. 100 Ml of this solution was added to the assay mixture and the reaction was initiated by adding 50 MI of[32P]NAD (50 gM, 10-50 Ci/mmol). Reactions were carried out for 90 min and quenched by the addition of an equal volume of ice cold buffer (100 mM Tris-HCI, pH 7.4, 5 mM MgCl2, and 1 mM EDTA) containing 1 mM NAD. Membranes were then pelleted and solubilized in sample buffer, and the constituent proteins were resolved on sodium dodecyl sulfate (SDS)-1 3% polyacrylamide gels as described (13) using the method of Laemmli (14) . A second assay was performed on each sample of sarcolemma using the same method except that cholera toxin was omitted from the reaction. Labeled bands were excised from the gel and counted. The corresponding region from lanes where cholera toxin was omitted was also cut out and counted to establish background. The molar amount of cholera toxin-specific incorporated label was calculated on the basis ofspecific activity of the [32P]NAD used in each experiment.
Reconstitution of G, into cyc-membranes. Using a method described by Sternweis and co-workers (15), cardiac sarcolemma (3 mg/ml membrane protein) was solubilized in 2% sodium cholate (recrystallized from ethanol) in a buffer of 20 mM Tris-HCl (pH 7.7), 1 mM EDTA, 1 mM dithiothreitol for 1 h on ice. The supernatant from a 20,000 g spin was heated at 30°C for 10 min to inactivate the solubilized catalytic unit. The extract was then diluted into 0.1% Lubrol (in the same buffer), and 15 MA was added to 25 Ml of cyc-membranes (60 Ag of membrane protein) and allowed to sit on ice for 30 min. Preactivation was then performed by adding 20 Ml of a buffer consisting of 125 mM Hepes, pH 8.0, 50 mM MgC12, 2.5 mM ATP, 500 MM GTP, I mM EDTA, 30 mM phosphocreatine, 350 U/ml creatine phosphokinase, and 2.5 mM cAMP, as well as 20 M1 of40 mM NaF, and followed by incubation at 300C for 20 min. Adenylate cyclase activity was then assayed by adding 5 X 106 cpm [Ca-32P]ATP and 8 X 103 cpm [3H]cAMP in 20 Ml and incubating for an additional 10 min at 30°C. The reaction was terminated by the addition of 100 MI of 2% SDS. After the addition of 800 Ml of H20, the amount of cAMP produced was determined as previously described (4) . The synthesis of cAMP was linear with time up to 20 min. The time required to attain maximum activity in the preactivation step was consistent with data published by Sternweis et al. (15) .
Na+,K+-ATPase activity was determined according to the method ofJones and Besch ( 12) . Protein concentrations were measured by the method of Lowry et al. (16) , and cyc-membranes were prepared according to Ross et al. ( 17) . ,8-Adrenergic receptor binding studies were performed as previously described (4) . Results were expressed as mean±SEM and were compared using the unpaired Student's t test. Significance was defined as P < 0.05.
Results
Characterization ofthe model. Table I demonstrates the hemodynamic and morphologic characteristics ofour canine model. Of note, the LV systolic pressures are significantly elevated (P < 0.01) and the LV free wall-to-body weight ratio is doubled (P < 0.01) in the dogs with heart failure. pmol/mg in LV failure, n = 4, vs. 1.71±0.49 pmol/mg in normals, n = 5, P < 0.03). Finally, the purity of sarcolemmal membranes was assayed using Na+,K+-ATPase as an independent marker. There was no significant difference in the group with LV failure (27.6±13.5 Amol Pi/h per mg protein, n = 4) when compared with normal controls (31.5±5.5 ,umol Pi/h per mg protein, n = 5). In addition, there was no significant difference in the yield of sarcolemma per wet weight ofleft ventricular tissue (normal, 10.0±1.4 mg/100 g, n = 5; LV failure, 9.5±2.5 mg/100 g, n = 4). These data confirm that the animals used in this study are hemodynamically and biochemically similar to those reported previously by this laboratory. Also, because the yields of sarcolemma and the specific activity of Na+,K+-ATPase were not different, the differences observed in sarcolemma from normal and failing LV are not due to contaminants in the membrane preparations. This is further supported by the observation that f3-adrenergic receptor density is increased in LV sarcolemma from animals with heart failure.
Cholera toxin[32P]NAD quantitation of G. Cholera toxin transfers an ADP-ribose group from NAD to the alpha subunit of G, (GS,) (7, 18) . When [32P]NAD is used as a substrate and the labeled components of the membrane preparation are resolved on SDS-polyacrylamide gels, G,a can be identified by autoradiography. Because cholera toxin transfers only one ADP-ribose moiety to one G., (18) , the labeled band containing G,, can be excised from the gel and counted to assess the molar amount of this species. It should be noted that only one band of 45 kD (Fig. 1, inset A (Fig. 1 A) ( unlabeled NAD (Fig. 1 B) ing. When the bands were excised and counted, B c( < 5% of the radiolabel seen in A, indicating that > 9' available G,< was labeled under these conditions. W method was used to assess levels of Gsa, a 59% re (P < 0.005) was seen in sarcolemma derived from fa when compared with normal control sarcolemma as strated by the bar graph in Fig. 1 .
Reconstitution of G, Activity of G, was also assess a reconstitution assay originally described by Stemns co-workers (15 failing LV were used in the reconstitution assay (Fig. 3) Lires evi-Further studies are needed to address this possibility.
ed. This
Although the cholera toxin and reconstitution data were )nditions concordant in that they showed a 50-60% reduction in G, poration content and activity in failing left ventricle, we wanted to enma from sure that the decrease in activity of G, as demonstrated by tcorpora-reconstitution studies was not due to the co-reconstitution of iring this an inhibitor. This possibility was addressed in the following trated by phy. Re4f Fig. 1 Figure 2 . Reconstitution of G, from sarcolemma into cyc-. Solubilized sarcolemma were reconstituted into a fixed amount of cycmembrane, and adenylate cyclase activity, stimulated by NaF, was measured. In the range where reconstituted adenylate cyclase activity is a linear function of the amount of sarcolemma added to each assay, a 50% reduction of activity was seen in assays using sarcolemma from failing LV when compared with normals. The data are from two experiments each with duplicate points for each animal at each sarcolemma concentration. manner. Equal quantities of sarcolemma from normal and failing hearts were mixed, and reconstituted adenylate cyclase activity was measured. This was compared with the reconstituted activity from either sarcolemma alone. Fig. 4 pressure overload of the left ventricle due to systemic hypertension, causing myocardial hypertrophy and then failure. We have shown that Gs, a component of the left ventricular membranes that is necessary to transduce the inotropic effects of catecholamines, is defective and/or deficient in the failing left ventricle. Because the failing heart is dependent on adrenergic drive to maintain and increase cardiac output (1), defects in this transduction mechanism would be expected to affect the ability of the hypertrophied heart to maintain the enhanced contractile state necessary in the setting of a persistently elevated ventricular pressure. It is then possible that an acquired defect in G., as we have described here, is responsible for hyporesponsiveness of the hypertrophied, failing left ventricle to adrenergic stimulation. Such a defect could therefore contribute to myocardial decompensation and the clinical syndrome of heart failure.
Bristow and co-workers (5) could account for a reduction from 50 to 10% in the fraction of fl-adrenergic receptor agonist high-affinity sites. Our previous studies (4) and the present data show a similar finding: a 50% reduction in G. (acquired in our model rather than genetically determined) was accompanied by the same reduction in fl-receptor agonist high-affinity sites.
Our understanding of the function of G proteins in the molecular mechanisms of transmembrane signal transduction is still incomplete. It is clear that this family of proteins is relevant in many mechanisms of hormonal and neural signaling. G, not only couples the fl-adrenergic receptor to adenylate cyclase but also couples many peptide and prostaglandin receptors to their intracellular effectors (6). Other members of this family of proteins are likely to play central roles in the regulation of ion fluxes across cell membranes as well (23) . Given the broad range of effector mechanisms coupled to G proteins, an acquired defect in one or more of these proteins may be causally related to the molecular mechanism(s) responsible for decompensation of the hypertrophied heart. The model of altered G protein function which we have described here offers an excellent opportunity to investigate these processes at the level ofprotein chemistry as well as that of molecular biology. Whether loss in G, activity in this animal model of heart failure represents a quantitative decrease in the level of this protein or a qualitative change owing to a transcriptional or posttranslational modification (24, 25) will require further investigation.
